Home
Home
News Feed
Free Newsletters
Medical News 'Tweets'
Talk Medical
News A-Z
Business / Finance
Child Health News
Device / Technology News
Disease/Infection News
Drug Trial News
Healthcare News
Medical Condition News
Medical Patent News
Medical Procedure News
Medical Research News
Medical Science News
Men's Health News
Miscellaneous News
Pharmaceutical News
Women's Health News
Alzheimer's
Arthritis
Asthma
Autism
Blood Pressure
Breast Cancer
Cancer
Cardiovascular Disease
Cellulitis
Cerebral Palsy
CLL
Cirrhosis
Crohn's Disease
Cystic Fibrosis
Depression
Diabetes
Diet
Eczema
Erectile Dysfunction
Fibromyalgia
Genetics
Glioblastoma
Gout
H1N1
H3N2
Hearing Loss
Heart Attack
Hepatitis
Herpes
HIVAIDS
Huntington's Disease
IVF
Lou Gehrig' Disease
Macular Degeneration
Mental Health
Multiple Sclerosis
Neurology
Nutrition
Obesity
Osteoarthritis
Pancreatic Cancer
Parkinson's Disease
Pneumonia
Pregnancy
Prostate Cancer
Retinitis Pigmentosa
Rheumatoid Arthritis
Schizophrenia
Sleep Apnea
Stem Cell
Stroke
Ulcerative Colitis
Vaccine
Virus
Health A-Z
Acne
Alzheimer's Disease
Antioxidant
Arthritis
Asthma
Atrial Fibrillation
Autism
Back Pain
Bipolar Disorder
Breast Cancer
Breastfeeding
Cancer
Cerebral Palsy
Cervical Cancer
Colon Cancer
Cystic Fibrosis
Dementia
Diabetes
Eating Disorder
Eczema
Epilepsy
Fibromyalgia
Folic Acid
Genetics
Glaucoma
Gout
Heart Attack
HIV/AIDS
Hypertension
Immunology
Impotence
Kidney Cancer
Leukemia
Lung Cancer
Malaria
Measles
Menopause
Obesity
Osteoporosis
Ovarian Cancer
Parkinson's Disease
Pediatrics
Prostate Cancer
Retinitis Pigmentosa
Rosacea
Schizophrenia
Skin Cancer
Stem Cell
Tuberculosis
Virus
West Nile Virus
Drugs A-Z
Abilify
Actilyse
Akamin
Amoxil Adult Preparations
Andriol Testocaps
Apo-Amlodipine
Apo-Atenolol
Apo-Clarithromycin
Apo-Clopidogrel
Apo-Gabapentin
Apo-Lansoprazole
Apo-Lisinopril
Apo-Omeprazole
APO-Oxazepam
Apo-Paracetamol Codeine
Apo-Tramadol SR
Arcoxia
Augmentin Syrup
Avil
Avomine
Bactrim
Bactroban Ointment
Bicor
Brufen
Buscopan Tablets
Clexane
Concerta
Coveram
Coversyl
Creon 10000; 25000; and 40000
Daonil
Dilatrend
Duodart
Dynastat
Epilim
Flagyl
Largactil
Lexotan
Lignocaine Injection
Loette
Metrogyl
Monofeme
Motilium
Nausetil
Norgesic
Noriday
Norspan
Norvasc
Nurofen 400 Double Strength
OxyContin
Panadol Cold & Flu Relief Original Formula
Rivotril
Serc
Stemetil
Stieva-A
Telfast
Valium
Voltaren
Zinnat
Zyprexa
Health Products
Autoclaves
Benchtop Sterilizers
Blood Gas Analyzers
Blood Glucose Monitors
Blood Pressure Monitors
CT Scanners
Defibrillators
DNA Sequencing / Analysis Systems
ECG Machines
Fetal Monitors
Fluorometers
Heart Rate Monitors
Hematology Blood Analyzers
Mammography Systems
MRI Scanners
Otoscopes / Auriscopes
Pregnancy Tests
Pulse Oximeters
Spirometers
Stethoscopes
Ultrasound Machines
Vital Signs Monitors
Health Services
Gastric Banding
Hair Transplantation
IVF Clinics
Lasik Eye Surgery
Liposuction
Australian Health Insurance
Canadian Health Insurance
U.S. Health Insurance
UK Health Insurance
News Archive
Info / About
Terms and Conditions
Medical News Letters
Free Magazines
May 27, 2012
Other search tools:
Drugs
|
Health
|
News
About
Terms
Latest News
New, more accurate test for paralytic shellfish poisons
Study: 10 percent of veterans go without health insurance
Muslim women, religious leaders being enlisted in global campaign to eradicate polio
Mass. hospital agrees to $750,000 settlement over 2010 data breach
Overactive BAALC gene found in people with acute leukemia
Senate Appropriations Committee approves FY13 state and foreign operations appropriations bill
Research roundup: Do mandatory screening laws affect disparities?; Mass. health law, 6 years later
Illinois legislature passes bill with deep Medicaid cuts
Special surface allows adult-derived stem cells to thrive and transform into multiple cell types
IPS reports on population and development conference draft declaration
Biotechnology
Blood Pressure
Bone
Brain
Breast Cancer
Cancer
Cell
Chemotherapy
Depression
Diabetes
Diagnostics
Diet
DNA
Education
Exercise
Gene
Genetics
Health and Human Services
Health Insurance
HIV
Hospital
Investment
Medicaid
Medicare
Muscle
Neurology
Neuroscience
Nursing
Nutrition
Obesity
Oncology
Pain
Placebo
Pregnancy
Prostate Cancer
Protein
Stress
Stroke
Translational
Vaccine
Read in |
English
|
Español
|
Français
|
Deutsch
|
Português
|
Italiano
|
日本語
|
한국어
| 简体中文 |
繁體中文
|
العربية
|
Dansk
|
Nederlands
|
Filipino
|
Finnish
|
Ελληνικά
|
עִבְרִית
|
हिन्दी
|
Bahasa
|
Norsk
|
Русский
|
Svenska
|
Magyar
|
Polski
|
Română
|
Türkçe
红斑狼疮的事实
Tweet
红斑狼疮是身体的慢性的自身免疫性疾病,这将导致各部分,尤其是身体的皮肤、 关节和肾脏炎症。它还可能会影响血液。通常,免疫系统保护身体免受病毒、 细菌和其他外国侵略者。在像红斑狼疮自身免疫性疾病,免疫系统失去它能够告诉外国物质和自己的细胞和组织之间的差异。然后,免疫系统使人体自身抗体。
红斑狼疮是不传染性、 稀有或癌。
虽然红斑狼疮的原因是未知的科学家怀疑个人基因易患红斑狼疮,并且也知道环境因素,如感染、 抗生素、 紫外线、 极端的压力和某些药物发挥关键作用,触发红斑狼疮。
红斑狼疮罢工成年妇女 10 到 15 倍比成年男性更频繁。
红斑狼疮是非裔美国人、 拉美人和亚洲人中更为普遍。美国黑人妇女是三次更有可能获得比白人女性红斑狼疮。非洲裔美国人和西班牙裔/裔都倾向于发展红斑狼疮的年纪和有更多的症状诊断 (包括肾脏问题)。
只有 10%的人为红斑狼疮将有近亲属 (父母或同级) 谁已经已经或可能发展红斑狼疮。只有约 5%的儿童出生于个人有红斑狼疮会得病。
红斑狼疮的人有时经验"光晕"。当某些症状短暂出现,然后消失时,将发生这种情况。即使你服用治疗红斑狼疮,您可能会发现有的时间时症状变得更糟。认识到 flare 来学习,可以帮助您采取步骤,以应付它。很多人觉得很累,或有疼痛、 出疹、 发烧、 胃部不适、 头痛或只是之前的 flare 头晕 … …。
红斑狼疮可能很难诊断症状转来和模仿的许多其它疾病。红斑狼疮的一些症状可能转瞬即逝,如关节及肌肉疼痛、 疲劳、 引起皮疹或做出更糟的阳光、 低品位发烧、 头发损失、 胸膜炎、 食欲,疼痛鼻子、 嘴里,或痛苦的敏感性的手指在寒冷的环境中。
症状红斑狼疮的范围可以从温和到危及生命和成千上万的美国人死于红斑狼疮并发症每年。
使用最佳的护理,大多数女性红斑狼疮可以无危害自己的健康有健康的宝宝。
进一步阅读
红斑狼疮是什么?
红斑狼疮症状
狼疮诊断
红斑狼疮照明弹
红斑狼疮治疗
红斑狼疮和怀孕
红斑狼疮和应力
Recent Lupus News
LabCorp, XDx partner to develop and commercialize SLE flare predictor test
XDx, Inc. announced today that it has entered into a collaboration and license agreement with Laboratory Corporation of America Holdings (LabCorp)whereby each party will collaborate in marker discover...
Severe hypersensitivity reactions to anti-HIV drug occur through autoimmune mechanism
Potentially severe hypersensitivity reactions to the anti-HIV drug abacavir occur through an autoimmune mechanism, resulting from the creation of drug-induced immunogens that are attacked by the body'...
Data from Janssen’s SIMPONI Phase 3 study on ulcerative colitis
New study findings presented today show that subcutaneous induction regimens of the anti-tumor necrosis factor (TNF)-alpha therapy SIMPONI (golimumab) induced clinical response in a majority of patien...
Ipsen, Active Biotech complete half of planned recruitment in tasquinimod phase III study for CRPC
Active Biotech and Ipsen today announced that recruitment to the global, pivotal, randomized, double-blind, placebo-controlled phase III study of tasquinimod in patients with metastatic castrate-resis...
Ipsen, Active Biotech to present data from tasquinimod phase II trial on CRPC at ASCO 2012
Active Biotech and Ipsen will present tasquinimod (TASQ), their prostate cancer drug candidate, at the scientific conference "2012 ASCO Annual Meeting" to be held in Chicago (USA) on 1-5 June 2012.